ME Trigg

1.4k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

ME Trigg is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, ME Trigg has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 7 papers in Public Health, Environmental and Occupational Health and 7 papers in Immunology. Recurrent topics in ME Trigg's work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Lymphoblastic Leukemia research (7 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). ME Trigg is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Acute Lymphoblastic Leukemia research (7 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). ME Trigg collaborates with scholars based in United States, Switzerland and Canada. ME Trigg's co-authors include G. Denman Hammond, NA Heerema, W. Archie Bleyer, S Rumelhart, H N Sather, James B. Nachman, Martha G. Sensel, P S Gaynon, Robert Hong and Roger Giller and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Clinical Nutrition.

In The Last Decade

ME Trigg

20 papers receiving 1.0k citations

Hit Papers

Long-term follow-up of imatinib in pediatric Philadelphia... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
    2014 304 citations Kirk R. Schultz, Andrew J. Carroll et al. Leukemia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
ME Trigg United States 12 676 636 386 199 197 21 1.0k
E. Odenwald Germany 11 681 1.0× 483 0.8× 408 1.1× 276 1.4× 170 0.9× 17 1.1k
Jill Durrant United Kingdom 11 980 1.4× 919 1.4× 333 0.9× 228 1.1× 70 0.4× 18 1.3k
MJ Schell United States 14 535 0.8× 636 1.0× 128 0.3× 258 1.3× 137 0.7× 17 1000
Nicholas J. Goulden United Kingdom 11 450 0.7× 531 0.8× 136 0.4× 196 1.0× 126 0.6× 23 826
Keiko Yumura‐Yagi Japan 18 383 0.6× 605 1.0× 150 0.4× 332 1.7× 343 1.7× 49 1.2k
H. Baurmann Germany 18 294 0.4× 757 1.2× 94 0.2× 211 1.1× 215 1.1× 61 1.2k
John Moppett United Kingdom 19 482 0.7× 397 0.6× 255 0.7× 230 1.2× 55 0.3× 46 925
Kimberly P. Dunsmore United States 15 552 0.8× 393 0.6× 299 0.8× 210 1.1× 154 0.8× 43 936
Inmaculada Heras Spain 17 288 0.4× 494 0.8× 175 0.5× 281 1.4× 163 0.8× 44 962
WG Woods United States 15 484 0.7× 937 1.5× 88 0.2× 307 1.5× 131 0.7× 26 1.3k

Countries citing papers authored by ME Trigg

Since Specialization
Citations

This map shows the geographic impact of ME Trigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ME Trigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ME Trigg more than expected).

Fields of papers citing papers by ME Trigg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ME Trigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ME Trigg. The network helps show where ME Trigg may publish in the future.

Co-authorship network of co-authors of ME Trigg

This figure shows the co-authorship network connecting the top 25 collaborators of ME Trigg. A scholar is included among the top collaborators of ME Trigg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ME Trigg. ME Trigg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schultz, Kirk R., Andrew J. Carroll, Nyla A. Heerema, et al.. (2014). Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031. Leukemia. 28(7). 1467–1471. 304 indexed citations breakdown →
2.
Trigg, ME & Rebecca C. Schugar. (2001). Chédiak–Higashi syndrome: hematopoietic chimerism corrects genetic defect. Bone Marrow Transplantation. 27(11). 1211–1213. 12 indexed citations
3.
Trigg, ME, et al.. (2000). Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995. Leukemia. 14(12). 2223–2233. 240 indexed citations
4.
Rumelhart, S, et al.. (2000). Poor outcome in children with refractory/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors. Bone Marrow Transplantation. 25(9). 943–948. 24 indexed citations
5.
Nachman, James B., H N Sather, Joel M. Cherlow, et al.. (1998). Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.. Journal of Clinical Oncology. 16(3). 920–930. 92 indexed citations
6.
Trigg, ME, et al.. (1997). Successful program to prevent aspergillus infections in children undergoing marrow transplantation: use of nasal amphotericin. Bone Marrow Transplantation. 19(1). 43–47. 21 indexed citations
7.
Uckun, Fatih M., P S Gaynon, Martha G. Sensel, et al.. (1997). Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.. Journal of Clinical Oncology. 15(6). 2214–2221. 81 indexed citations
8.
9.
10.
Rumelhart, S, et al.. (1990). Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome. Blood. 75(4). 1031–1035. 4 indexed citations
11.
Rumelhart, S, et al.. (1990). Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome. Blood. 75(4). 1031–1035. 27 indexed citations
12.
Trigg, ME, R. Gingrich, Nancy E. Goeken, et al.. (1989). Low rejection rate when using unrelated or haploidentical donors for children with leukemia undergoing marrow transplantation.. PubMed. 4(4). 431–7. 22 indexed citations
13.
Trigg, ME, et al.. (1988). Aspergillus coronary embolization causing acute myocardial infarction.. PubMed. 3(3). 229–33. 10 indexed citations
14.
Hong, Robert, RC Moen, ME Trigg, et al.. (1987). Thymus and B cell reconstitution in severe combined immunodeficiency after transplantation of monoclonal antibody depleted parental mismatched bone marrow.. PubMed. 1(4). 405–9. 8 indexed citations
15.
16.
17.
Trigg, ME. (1986). The decision in pediatrics to go ahead with bone marrow transplant for a pediatric malignancy.. PubMed. 1(2). 111–4. 1 indexed citations
18.
Trigg, ME, Alan C. Peterson, Marek J. Bozdech, et al.. (1986). Depletion of T cells from bone marrow for allogeneic transplantation: method for treatment of bone marrow in bulk.. PubMed. 14(1). 21–6. 16 indexed citations
19.
20.
Trigg, ME, et al.. (1975). Addition of leucine precursors to the diet of leucine-starved mice. American Journal of Clinical Nutrition. 28(9). 947–949.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Odenwald Breakdown of academic impact, for papers by Jill Durrant Breakdown of academic impact, for papers by MJ Schell Breakdown of academic impact, for papers by Nicholas J. Goulden Breakdown of academic impact, for papers by Keiko Yumura‐Yagi Breakdown of academic impact, for papers by H. Baurmann Breakdown of academic impact, for papers by John Moppett Breakdown of academic impact, for papers by Kimberly P. Dunsmore Breakdown of academic impact, for papers by Inmaculada Heras Breakdown of academic impact, for papers by WG Woods
Rankless by CCL
2026